Description
Rituximab, marketed under the brand name RITUXAN, It is an prescription medication that has been approved rituximab (brand name Rituxan) on November 26, 1997. It was the first monoclonal antibody approved to treat lymphoma.
What is RITUXAN (rituximab) ?
RITUXAN (rituximab) is a CD20-directed cytolytic antibody indicated for the treatment of:
- Adult patients with Non-Hodgkin’s Lymphoma (NHL).
- Adult patients with Chronic Lymphocytic Leukemia (CLL).
- Rheumatoid Arthritis (RA) in combination with methotrexate in adult patients with moderately-to severely-active RA who ha
ve inadequate response to one or more TNF antagonist therapies. • Granulomatosis with Polyangiitis (GPA) (Wegener’s Granulomatosis) and Microscopic Polyangiitis (MPA) in adult and pediatric patients 2 years of age and older in combination with glucocorticoids.
- Moderate to severe Pemphigus Vulgaris (PV) in adult patients.
How to order approved “RITUXAN (rituximab) for Injection” Medicine?
RITUXAN (Rituximab) injection is a prescription medicine, it can be accessed through the Named Patient Program (NPP) for treatment in the following city of India – Bengaluru, Delhi, Chennai, Hyderabad, Mumbai, Pune, Kolkata, Ahmedabad, Gurgaon. To inquire about the cost price of purchasing RITUXAN and arranging delivery to your location, please get in touch with Mr. Rakesh at +91 9910645395 or send an enquiry to info@cancermedicinesnetwork. We assure you of the quality of the product and guarantee delivery in accordance with your specific requirements.
